Diasorin Gets FDA 510(k) Clearance for New Multiplexing Platform
Diasorin received FDA 510(k) clearance for its new Liaison Plex platform and first panel of tests, the Liaison Plex Respiratory Flex Assay.
Read MorePosted by Andy Lundin | Mar 4, 2024 | Diagnostic Technologies, Respiratory Disease |
Diasorin received FDA 510(k) clearance for its new Liaison Plex platform and first panel of tests, the Liaison Plex Respiratory Flex Assay.
Read MorePosted by Andy Lundin | Feb 28, 2024 | Diagnostic Technologies |
While not a substitute for medical advice, epigenetic testing offers individuals a proactive approach to managing their health.
Read MorePosted by Chris Wolski | Feb 28, 2024 | Lab Management |
Workflow analysis, supported by a partner, is key to helping labs identify strategies and implement changes that boost their efficiency.
Read MorePosted by Andy Lundin | Feb 27, 2024 | Molecular Diagnostics |
Researchers developed a lower-cost method to detect nuclease digestion—one of the critical steps in many nucleic acid sensing applications.
Read MorePosted by Chris Wolski | Feb 26, 2024 | Breast |
For patients with metastatic HR+ breast cancer, there may be no test more important than monitoring for an ESR1 mutation.
Read More